tiprankstipranks
Trending News
More News >
Cardinal Health (CAH)
NYSE:CAH
US Market

Cardinal Health (CAH) Ratios

Compare
2,197 Followers

Cardinal Health Ratios

CAH's free cash flow for Q3 2025 was $0.04. For the 2025 fiscal year, CAH's free cash flow was decreased by $ and operating cash flow was $0.01. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
0.98 1.00 1.08 1.12 1.10
Quick Ratio
0.56 0.53 0.57 0.60 0.54
Cash Ratio
0.14 0.12 0.15 0.12 0.12
Solvency Ratio
0.03 0.02 >-0.01 0.03 -0.07
Operating Cash Flow Ratio
0.11 0.08 0.10 0.09 0.08
Short-Term Operating Cash Flow Coverage
8.67 3.58 5.38 2.79 196.00
Net Current Asset Value
$ -13.45B$ -12.44B$ -11.65B$ -11.61B$ -13.03B
Leverage Ratios
Debt-to-Assets Ratio
0.11 0.11 0.12 0.14 0.17
Debt-to-Equity Ratio
-1.58 -1.65 -7.53 3.48 3.78
Debt-to-Capital Ratio
2.71 2.54 1.15 0.78 0.79
Long-Term Debt-to-Capital Ratio
3.22 3.69 1.18 0.75 0.79
Financial Leverage Ratio
-14.04 -15.23 -62.15 24.78 22.75
Debt Service Coverage Ratio
3.25 1.21 -0.05 1.52 -10.23
Interest Coverage Ratio
18.55 8.45 9.58 10.12 7.45
Debt to Market Cap
0.21 0.19 0.36 0.37 0.44
Interest Debt Per Share
21.06 18.34 19.67 21.98 23.94
Net Debt to EBITDA
-0.02 0.46 4.75 2.16 -1.53
Profitability Margins
Gross Profit Margin
3.27%3.36%3.61%4.17%4.49%
EBIT Margin
0.55%0.36%-0.35%0.31%-2.31%
EBITDA Margin
0.87%0.70%0.07%0.81%-1.71%
Operating Profit Margin
0.55%0.35%0.91%1.13%1.16%
Pretax Profit Margin
0.53%0.31%-0.42%0.20%-2.47%
Net Profit Margin
0.38%0.13%-0.51%0.38%-2.41%
Continuous Operations Profit Margin
0.38%0.16%-0.51%0.38%-2.41%
Net Income Per EBT
70.94%40.91%121.20%189.16%97.91%
EBT Per EBIT
96.62%87.76%-46.66%17.54%-212.75%
Return on Assets (ROA)
1.89%0.60%-2.12%1.37%-9.06%
Return on Equity (ROE)
-26.52%-9.15%132.01%34.06%-206.08%
Return on Capital Employed (ROCE)
13.11%7.49%12.36%10.94%10.34%
Return on Invested Capital (ROIC)
8.90%2.84%14.36%19.71%10.12%
Return on Tangible Assets
2.20%0.70%-2.57%1.78%-12.52%
Earnings Yield
3.56%1.06%-6.39%3.67%-24.15%
Efficiency Ratios
Receivables Turnover
18.75 18.46 17.17 17.85 18.50
Payables Turnover
6.91 6.62 6.44 6.57 6.83
Inventory Turnover
14.67 12.43 11.18 10.67 11.07
Fixed Asset Turnover
75.51 83.27 76.82 68.84 64.63
Asset Turnover
5.03 4.72 4.13 3.65 3.75
Working Capital Turnover Ratio
-721.23 163.23 62.44 56.52 77.17
Cash Conversion Cycle
-8.48 -6.00 -2.74 -0.90 -0.71
Days of Sales Outstanding
19.47 19.78 21.25 20.45 19.72
Days of Inventory Outstanding
24.88 29.37 32.65 34.21 32.98
Days of Payables Outstanding
52.83 55.15 56.64 55.56 53.42
Operating Cycle
44.35 49.14 53.90 54.67 52.71
Cash Flow Ratios
Operating Cash Flow Per Share
15.36 10.88 11.19 8.32 6.69
Free Cash Flow Per Share
13.27 9.03 9.80 6.95 5.41
CapEx Per Share
2.09 1.84 1.39 1.37 1.28
Free Cash Flow to Operating Cash Flow
0.86 0.83 0.88 0.84 0.81
Dividend Paid and CapEx Coverage Ratio
3.72 2.82 3.30 2.50 2.08
Capital Expenditure Coverage Ratio
7.36 5.90 8.07 6.07 5.23
Operating Cash Flow Coverage Ratio
0.74 0.60 0.59 0.39 0.29
Operating Cash Flow to Sales Ratio
0.02 0.01 0.02 0.01 0.01
Free Cash Flow Yield
13.57%9.55%18.75%12.17%10.37%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
28.11 94.57 -15.65 27.28 -4.14
Price-to-Sales (P/S) Ratio
0.11 0.12 0.08 0.10 0.10
Price-to-Book (P/B) Ratio
-7.45 -8.66 -20.66 9.29 8.53
Price-to-Free Cash Flow (P/FCF) Ratio
7.37 10.47 5.33 8.22 9.65
Price-to-Operating Cash Flow Ratio
6.37 8.69 4.67 6.86 7.80
Price-to-Earnings Growth (PEG) Ratio
0.11 -0.73 0.06 -0.23 0.01
Price-to-Fair Value
-7.45 -8.66 -20.66 9.29 8.53
Enterprise Value Multiple
12.09 17.59 120.49 14.88 -7.37
Enterprise Value
23.91B 25.34B 15.18B 19.50B 19.30B
EV to EBITDA
12.09 17.59 120.49 14.88 -7.37
EV to Sales
0.11 0.12 0.08 0.12 0.13
EV to Free Cash Flow
7.35 10.75 5.55 9.61 12.17
EV to Operating Cash Flow
6.36 8.93 4.86 8.03 9.84
Tangible Book Value Per Share
-39.44 -34.22 -29.87 -28.42 -32.37
Shareholders’ Equity Per Share
-13.11 -10.92 -2.53 6.14 6.12
Tax and Other Ratios
Effective Tax Rate
0.29 0.59 -0.21 -0.89 0.02
Revenue Per Share
925.82 785.49 650.05 556.39 521.92
Net Income Per Share
3.48 1.00 -3.34 2.09 -12.60
Tax Burden
0.71 0.41 1.21 1.89 0.98
Interest Burden
0.96 0.85 1.21 0.64 1.07
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
4.42 10.84 -3.35 3.97 -0.53
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis